Derivations of Response Status from SDTM Domains using RECIST 1.1
Best overall response during follow-up for all 54 patients. CR,... | Download Scientific Diagram
Durable Response Rate
Efficacy I PLUVICTO
ABECMA Results | ABECMA® (idecabtagene vicleucel)
Relationship between A) overall response rate (ORR), B) complete... | Download Scientific Diagram
Best Overall Response and Time to Response | Download Table
Metrics and inference - Overall response time | Online Help Site24x7
Overall response rate | Download Table
BCMA-targeted CAR-T shows 'outstanding responses' in advanced multiple myeloma
Objective response rate of placebo in randomized controlled trials of anticancer medicines - eClinicalMedicine
Best overall response when confirmation of CR and PR required. | Download Table
Metrics and inference - Overall response time | Online Help Site24x7
Best overall response (per RECIST 1.1, based on investigator assessment) | Download Scientific Diagram
Cell therapy doubles survival, response rates in advanced melanoma
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Disease Response Swimmer Plot
Efficacy | Tivdak® (tisotumab vedotin-tftv)
SAS Macro for Derivation of Best Overall Response per RECIST 1.1
PADCEV® (enfortumab vedotin-ejfv) Efficacy in Patients with la/mUC
ORR (Objective Response Rate) and related statistics – Part 1
Efficacy I PLUVICTO
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Predicting immunotherapy responses using circulating tumor DNA
Complete response and survival outcomes in patients with advanced cancer on immune checkpoint inhibitors | Immunotherapy
Nexcella Announces Positive 58-Patient NXC- 201 Clinical Data: 100% Overall Response Rate in light chain (AL) Amyloidosis; 92% Overall Response Rate in Multiple Myeloma at the EBMT 49th Annual Meeting in Paris | BioSpace
